Clinico-pathological Significance of TCGA Classification and SWI/SNF Proteins Expression in Undifferentiated/dedifferentiated Endometrial Carcinoma: A Possible Prognostic Risk Stratification
Overview
Authors
Affiliations
Background: Undifferentiated/dedifferentiated endometrial carcinoma (UEC/DDEC) is a heterogeneous entity, which may show any of the TCGA molecular signatures and loss of the switch/sucrose nonfermentable (SWI/SNF) proteins expression.
Aim: To assess the clinico-pathological significance of the TCGA molecular groups and SWI/SNF proteins expression in UEC/DDEC, through a quantitative systematic review.
Methods: Electronic databases were searched for all studies assessing the TCGA molecular groups, i.e. POLE-mutant, mismatch repair-deficient (MMRd), p53-abnormal (p53abn) and no specific molecular profile (NSMP), and/or the SWI/SNF proteins (SMARCA4/BRG1, SMARCB1/INI1, ARID1B) expression in UEC/DDEC. Student t-test, Fisher's exact test and Kaplan-Meier survival analysis with long-rank test were used to assess differences among groups; a p-value<0.05 was considered significant.
Results: Eight studies were included in the systematic review. Among the TCGA groups, the mean patient age was significantly higher in the p53abn group than in the NSMP group (p = 0.048). The POLE-mutant group showed advanced FIGO stage (III-IV) significantly less commonly than the NSMP (p = 0.003) and MMRd (p = 0.008) groups, and a significantly better prognosis than the NSMP (p = 0.007), MMRd (p = 0.011) and p53abn (p = 0.045) groups.The SWI/SNF-deficient cases showed a significantly worse prognosis than the SWI/SNF-intact cases (p = 0.010), while no significant differences were found regarding patient age and FIGO stage.
Conclusions: Among UEC/DDEC, POLE-mutant cases show good prognosis, while SWI/SNF-deficient cases show poor prognosis. The other TCGA molecular subtypes seem to be characterized by an intermediate biological behaviour. On this account, UEC/DDEC patients might be subdivided into three risk groups based on POLE and SWI/SNF status. Further studies are necessary in this field.
Wang Y, Zheng Y, Tian C, Yu J, Rao K, Zeng N J Inflamm Res. 2024; 17:11437-11449.
PMID: 39735898 PMC: 11675361. DOI: 10.2147/JIR.S494716.
Santoro A, Angelico G, Travaglino A, Inzani F, Arciuolo D, dAmati A Int J Mol Sci. 2024; 25(19).
PMID: 39408649 PMC: 11477420. DOI: 10.3390/ijms251910320.
Yasuda M Pathol Int. 2024; 74(10):557-573.
PMID: 39175262 PMC: 11551833. DOI: 10.1111/pin.13471.
Addante F, dAmati A, Santoro A, Angelico G, Inzani F, Arciuolo D Int J Mol Sci. 2024; 25(2).
PMID: 38256131 PMC: 10816607. DOI: 10.3390/ijms25021056.
H3K27me3 deficiency in dedifferentiated carcinoma and carcinosarcoma of the endometrium.
Kihara A, Amano Y, Fukushima N, Fujiwara H, Niki T Virchows Arch. 2023; 483(6):885-890.
PMID: 37770766 DOI: 10.1007/s00428-023-03665-9.